Home
All Journals
Expert Opinion on Therapeutic Targets
List of Issues
Volume 19, Issue 3

Expert Opinion on Therapeutic Targets

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Therapeutic Targets, Volume 19, Issue 3 (2015)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Therapeutic Targets, Volume 19, Issue 3 (2015)

See all volumes and issues

Vol 28, 2024 Vol 27, 2023 Vol 26, 2022 Vol 25, 2021 Vol 24, 2020 Vol 23, 2019 Vol 22, 2018 Vol 21, 2017 Vol 20, 2016 Volume 19, 2015 Vol 18, 2014 Vol 17, 2013 Vol 16, 2012 Vol 15, 2011 Vol 14, 2010 Vol 13, 2009 Vol 12, 2008 Vol 11, 2007 Vol 10, 2006 Vol 9, 2005 Vol 8, 2004 Vol 7, 2003 Vol 6, 2002 Vol 5, 2001 Vol 5, 2001 Vol 4, 2000 Vol 3, 1999 Vol 2, 1998 Vol 1, 1997

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Original Research

Article

Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment

Athanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, Athina Gkiomisi, Grigorios Sakellariou, Matthaios Savvidis, Athanasios Papatheodorou, Panagiotis Kokkoris & Evangelos Terpos

Pages: 299-306

Published online: 14 Nov 2014

AbstractforCirculating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment | Full Text | References | PDF (172.7 KB)

1686 Views
15 CrossRef citations
0Altmetric

Free Access

Article

Nobiletin inhibits invasion and migration of human nasopharyngeal carcinoma cell lines by involving ERK1/2 and transcriptional inhibition of MMP-2

Su-Yu Chien, Ming-Ju Hsieh, Chih-Jung Chen, Shun-Fa Yang & Mu-Kuan Chen

Pages: 307-320

Published online: 07 Jan 2015

AbstractforNobiletin inhibits invasion and migration of human nasopharyngeal carcinoma cell lines by involving ERK1/2 and transcriptional inhibition of MMP-2 | Full Text | References | PDF (1.1 MB) | Supplemental

274 Views
35 CrossRef citations
0Altmetric

Review

Emerging therapeutic targets for Gaucher disease

Einat B Vitner, Ayelet Vardi, Timothy M Cox & Anthony H Futerman

Pages: 321-334

Published online: 21 Nov 2014

AbstractforEmerging therapeutic targets for Gaucher disease | Full Text | References | PDF (694.7 KB)

962 Views
16 CrossRef citations
0Altmetric

Transglutaminase as a therapeutic target for celiac disease

Ana-Marija Sulic, Kalle Kurppa, Tiina Rauhavirta, Katri Kaukinen & Katri Lindfors

Pages: 335-348

Published online: 20 Nov 2014

AbstractforTransglutaminase as a therapeutic target for celiac disease | Full Text | References | PDF (552 KB)

665 Views
17 CrossRef citations
0Altmetric

Disialoganglioside GD2 as a therapeutic target for human diseases

Maya Suzuki MD & Nai-Kong V Cheung MD PhD

Pages: 349-362

Published online: 20 Jan 2015

AbstractforDisialoganglioside GD2 as a therapeutic target for human diseases | Full Text | References | PDF (467.9 KB)

2000 Views
116 CrossRef citations
0Altmetric

The role of polycomb repressive complexes in biliary tract cancer

Christian Mayr MSc, Daniel Neureiter, Andrej Wagner, Martin Pichler & Tobias Kiesslich

Pages: 363-375

Published online: 26 Nov 2014

AbstractforThe role of polycomb repressive complexes in biliary tract cancer | Full Text | References | PDF (620.6 KB)

326 Views
16 CrossRef citations
0Altmetric

Dopamine heteroreceptor complexes as therapeutic targets in Parkinson’s disease

Kjell Fuxe (Professor) MD PhD, Diego Guidolin PhD, Luigi F Agnati (Professor) MD PhD & Dasiel O Borroto-Escuela PhD MBA

Pages: 377-398

Published online: 08 Dec 2014

AbstractforDopamine heteroreceptor complexes as therapeutic targets in Parkinson’s disease | Full Text | References | PDF (808.1 KB)

670 Views
68 CrossRef citations
0Altmetric

The potential of targeting NMDA receptors outside the CNS

Milica Bozic (Postdoctoral Fellow) PhD & José M Valdivielso (Director of the Nephrology Research Department) PhD

Pages: 399-413

Published online: 13 Dec 2014

AbstractforThe potential of targeting NMDA receptors outside the CNS | Full Text | References | PDF (450 KB)

836 Views
53 CrossRef citations
0Altmetric

The molecular mechanisms and therapeutic potential of microRNA-7 in cancer

Dian-Na Gu MD, Qian Huang MD PhD & Ling Tian PhD

Pages: 415-426

Published online: 29 Nov 2014

AbstractforThe molecular mechanisms and therapeutic potential of microRNA-7 in cancer | Full Text | References | PDF (540.3 KB)

435 Views
32 CrossRef citations
0Altmetric

The potential of class 3 semaphorins as both targets and therapeutics in cancer

Rosalin Mishra, Dhiraj Kumar, Deepti Tomar, Goutam Chakraborty, Santosh Kumar & Gopal C Kundu

Pages: 427-442

Published online: 29 Nov 2014

AbstractforThe potential of class 3 semaphorins as both targets and therapeutics in cancer | Full Text | References | PDF (824.6 KB)

403 Views
6 CrossRef citations
0Altmetric

Interview

A key opinion leader interview with Prof D Santini: insight into cancer research

Claudia Palmer (Commissioning Editor) & Daniele Santini (Professor)

Pages: 443-445

Published online: 16 Feb 2015

First Page PreviewforA key opinion leader interview with Prof D Santini: insight into cancer research | Full Text | PDF (171.3 KB)

129 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Candidate molecular targets uncovered in mouse lifespan extension studies

Maria Vedunova et al.

Review Article | Published online: 30 Apr 2024

The role of Collagen Triple Helix Repeat Containing 1 (CTHRC1) in cancer development and progression

Chandra K. Singh et al.

Review Article | Published online: 30 Apr 2024

Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress

Hui Chen et al.

Report | Published online: 29 Apr 2024

Arenobufagin induces cell apoptosis by modulating the cell cycle regulator claspin and the JNK pathway in nasopharyngeal carcinoma cells

Hsin-Yu Ho et al.

Article | Published online: 27 Apr 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Therapeutic Targets (Vol.19, Iss.3, 2015)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?